Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone plus Ropivacaine for Post-Craniotomy Pain
NCT03618264Phase 4Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Apr 2019
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Cumulative sufentanil consumption within 48 hours postoperatively. Started Apr 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03618264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03618264.